Literature DB >> 30264779

Clinical uses of botulinum toxin A in smile aesthetic modification.

S N Delpachitra1, A W Sklavos2, M Dastaran3.   

Abstract

In this article we review the pharmacodynamics of commercially available preparations of botulinum toxin type A, and discuss the potential uses of the drug in smile modification. A major emphasis is placed on applications relevant to modern dental practice, and to the complications arising from its use. Botulinum toxin A, when applied correctly, is a safe and effective means of achieving aesthetic smile modification, with limited data on any demonstrable long-term adverse effects.

Mesh：

Substances：

Year:  2018        PMID： 30264779     DOI： 10.1038/sj.bdj.2018.755

Source DB:  PubMed          Journal:  Br Dent J        ISSN： 0007-0610            Impact factor:   1.626


  29 in total

Review 1.  Complications and adverse reactions with the use of botulinum toxin.

Authors:  Arnold William Klein
Journal:  Dis Mon       Date:  2002-05       Impact factor: 3.800

Review 2.  Injectable neurotoxins and fillers: there is no free lunch.

Authors:  Jason Emer; Heidi Waldorf
Journal:  Clin Dermatol       Date:  2011 Nov-Dec       Impact factor: 3.541

3.  Botox and Dysport: is there a dose conversion ratio in dermatology and aesthetic medicine?

Authors:  Syrus Karsai; Christian Raulin
Journal:  J Am Acad Dermatol       Date:  2010-02       Impact factor: 11.527

Review 4.  The aesthetic smile: diagnosis and treatment.

Authors:  D A Garber; M A Salama
Journal:  Periodontol 2000       Date:  1996-06       Impact factor: 7.589

5.  Cosmetic denervation of the muscles of facial expression with botulinum toxin. A dose-response study.

Authors:  A Garcia; J E Fulton
Journal:  Dermatol Surg       Date:  1996-01       Impact factor: 3.398

6.  Botulinum toxin: mechanism of presynaptic blockade.

Authors:  I Kao; D B Drachman; D L Price
Journal:  Science       Date:  1976-09-24       Impact factor: 47.728

7.  Predicting soft tissue profile changes concurrent with orthodontic treatment.

Authors:  F Yogosawa
Journal:  Angle Orthod       Date:  1990       Impact factor: 2.079

8.  An analysis of the long-term safety data of repeat administrations of botulinum neurotoxin type A-ABO for the treatment of glabellar lines.

Authors:  Joel L Cohen; Joel Schlessinger; Sue Ellen Cox; Xiaoming Lin
Journal:  Aesthet Surg J       Date:  2009-11       Impact factor: 4.283

9.  Chin, nose, and lips. Normal ratios in young men and women.

Authors:  G L Skinazi; S J Lindauer; R J Isaacson
Journal:  Am J Orthod Dentofacial Orthop       Date:  1994-11       Impact factor: 2.650

10.  Botulinum toxin type A (Botox) for the neuromuscular correction of excessive gingival display on smiling (gummy smile).

Authors:  Mario Polo
Journal:  Am J Orthod Dentofacial Orthop       Date:  2008-02       Impact factor: 2.650
View more
  1 in total

1.  The effect of botulinum toxin A in patients with excessive gingival display with and without zinc supplementation: randomized clinical trial.

Authors:  Nesma Shemais; Azza Ezz Elarab; Hani ElNahass
Journal:  Clin Oral Investig       Date:  2021-05-05       Impact factor: 3.573
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.